{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:34:47Z","timestamp":1794353687807,"version":"4.9.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02512-x","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:35:50Z","timestamp":1741671350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Lipidomics and genomics in mental health: insights into major depressive disorder, bipolar disorder, schizophrenia, and obsessive-compulsive disorder"],"prefix":"10.1186","volume":"24","author":[{"given":"Martina Nicole","family":"Modesti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Francesco","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Del Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Borro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Parmigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Simmaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Guariglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ferracuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2512_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793\u20135.","journal-title":"N Engl J Med"},{"key":"2512_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","volume":"15","author":"BS Fernandes","year":"2017","unstructured":"Fernandes BS, Williams LM, Steiner J, Leboyer M, Carvalho AF, Berk M. The new field of \u201cprecision psychiatry.\u201d BMC Med. 2017;15:80.","journal-title":"BMC Med"},{"key":"2512_CR3","first-page":"393","volume":"21","author":"DJ Stein","year":"2022","unstructured":"Stein DJ, Shoptaw SJ, Vigo DV, Lund C, Cuijpers P, Bantjes J, et al. Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration. World Psychiatry Off J World Psychiatr Assoc WPA. 2022;21:393\u2013414.","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"key":"2512_CR4","first-page":"236","volume":"22","author":"A Abi-Dargham","year":"2023","unstructured":"Abi-Dargham A, Moeller SJ, Ali F, DeLorenzo C, Domschke K, Horga G, et al. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry Off J World Psychiatr Assoc WPA. 2023;22:236\u201362.","journal-title":"World Psychiatry Off J World Psychiatr Assoc WPA"},{"key":"2512_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/acps.12461","volume":"132","author":"JC van der Stel","year":"2015","unstructured":"van der Stel JC. Precision in psychiatry. Acta Psychiatr Scand. 2015;132:310\u20131.","journal-title":"Acta Psychiatr Scand"},{"key":"2512_CR6","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1017\/S0033291724000370","volume":"54","author":"E van Dellen","year":"2024","unstructured":"van Dellen E. Precision psychiatry: predicting predictability. Psychol Med. 2024;54:1500\u20139.","journal-title":"Psychol Med"},{"key":"2512_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tins.2022.12.004","volume":"46","author":"H Hampel","year":"2023","unstructured":"Hampel H, Gao P, Cummings J, Toschi N, Thompson PM, Hu Y, et al. The foundation and architecture of precision medicine in neurology and psychiatry. Trends Neurosci. 2023;46:176\u201398.","journal-title":"Trends Neurosci"},{"key":"2512_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1017\/neu.2022.31","volume":"35","author":"M Maes","year":"2023","unstructured":"Maes M, Moraes JB, Congio A, Vargas H, Nunes S. Research and Diagnostic Algorithmic Rules (RADAR) for mood disorders, recurrence of illness, suicidal behaviours, and the patient\u2019s lifetime trajectory. Acta Neuropsychiatr. 2023;35:104\u201317.","journal-title":"Acta Neuropsychiatr"},{"key":"2512_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5498\/wjp.v11.i1.1","volume":"11","author":"D Stoyanov","year":"2021","unstructured":"Stoyanov D, Maes MH. How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry. World J Psychiatry. 2021;11:1\u201312.","journal-title":"World J Psychiatry"},{"key":"2512_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-021-02910-6","volume":"19","author":"D Hartl","year":"2021","unstructured":"Hartl D, de Luca V, Kostikova A, Laramie J, Kennedy S, Ferrero E, et al. Translational precision medicine: an industry perspective. J Transl Med. 2021;19:245.","journal-title":"J Transl Med"},{"key":"2512_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s10038-022-01059-4","volume":"68","author":"H Kato","year":"2023","unstructured":"Kato H, Kimura H, Kushima I, Takahashi N, Aleksic B, Ozaki N. The genetic architecture of schizophrenia: review of large-scale genetic studies. J Hum Genet. 2023;68:175\u201382.","journal-title":"J Hum Genet"},{"key":"2512_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/ijms24010578","volume":"24","author":"S Harsanyi","year":"2022","unstructured":"Harsanyi S, Kupcova I, Danisovic L, Klein M. Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation? Int J Mol Sci. 2022;24:578.","journal-title":"Int J Mol Sci"},{"key":"2512_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/antiox11071386","volume":"11","author":"Z Lu","year":"2022","unstructured":"Lu Z, Pu C, Zhang Y, Sun Y, Liao Y, Kang Z, et al. Oxidative Stress and Psychiatric Disorders: Evidence from the Bidirectional Mendelian Randomization Study. Antioxid Basel Switz. 2022;11:1386.","journal-title":"Antioxid Basel Switz"},{"key":"2512_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/HRP.0000000000000167","volume":"26","author":"MW Miller","year":"2018","unstructured":"Miller MW, Lin AP, Wolf EJ, Miller DR. Oxidative Stress, Inflammation, and Neuroprogression in Chronic PTSD. Harv Rev Psychiatry. 2018;26:57\u201369.","journal-title":"Harv Rev Psychiatry"},{"key":"2512_CR15","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/ijms23042032","volume":"23","author":"B Pinto","year":"2022","unstructured":"Pinto B, Conde T, Domingues I, Domingues MR. Adaptation of Lipid Profiling in Depression Disease and Treatment: A Critical Review. Int J Mol Sci. 2022;23:2032.","journal-title":"Int J Mol Sci"},{"key":"2512_CR16","doi-asserted-by":"publisher","first-page":"137791","DOI":"10.1016\/j.neulet.2024.137791","volume":"831","author":"D Cavaleri","year":"2024","unstructured":"Cavaleri D, Riboldi I, Crocamo C, Paglia G, Carr\u00e0 G, Bartoli F. Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine. Neurosci Lett. 2024;831: 137791.","journal-title":"Neurosci Lett"},{"key":"2512_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","volume":"195","author":"J Davison","year":"2018","unstructured":"Davison J, O\u2019Gorman A, Brennan L, Cotter DR. A systematic review of metabolite biomarkers of schizophrenia. Schizophr Res. 2018;195:32\u201350.","journal-title":"Schizophr Res"},{"key":"2512_CR18","doi-asserted-by":"publisher","first-page":"774","DOI":"10.5498\/wjp.v11.i10.774","volume":"11","author":"K Kouter","year":"2021","unstructured":"Kouter K, Videtic PA. \u201cOmics\u201d of suicidal behaviour: A path to personalised psychiatry. World J Psychiatry. 2021;11:774\u201390.","journal-title":"World J Psychiatry"},{"key":"2512_CR19","doi-asserted-by":"publisher","first-page":"115955","DOI":"10.1016\/j.psychres.2024.115955","volume":"339","author":"SN Wright","year":"2024","unstructured":"Wright SN, Anticevic A. Generative AI for precision neuroimaging biomarker development in psychiatry. Psychiatry Res. 2024;339: 115955.","journal-title":"Psychiatry Res"},{"key":"2512_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41386-024-01917-z","volume":"50","author":"LM Williams","year":"2024","unstructured":"Williams LM, Whitfield GS. Neuroimaging for precision medicine in psychiatry. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2024;50:246\u201357.","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"key":"2512_CR21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/a-1211-2826","volume":"88","author":"GM Giordano","year":"2020","unstructured":"Giordano GM, Pezzella P, Perrottelli A, Galderisi S. Die, \u201cPr\u00e4zisionspsychiatrie\u201d muss Teil der \u201cpersonalisierten Psychiatrie\u201d werden. Fortschr Neurol Psychiatr. 2020;88:767\u201372.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"2512_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-030-21735-8_10","volume":"1161","author":"P-AB Shih","year":"2019","unstructured":"Shih P-AB. Metabolomics Biomarkers for Precision Psychiatry. Adv Exp Med Biol. 2019;1161:101\u201313.","journal-title":"Adv Exp Med Biol."},{"key":"2512_CR23","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","volume":"99","author":"DS Wishart","year":"2019","unstructured":"Wishart DS. Metabolomics for Investigating Physiological and Pathophysiological Processes. Physiol Rev. 2019;99:1819\u201375.","journal-title":"Physiol Rev"},{"key":"2512_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbalip.2014.08.011","volume":"1851","author":"G Cermenati","year":"2015","unstructured":"Cermenati G, Mitro N, Audano M, Melcangi RC, Crestani M, De Fabiani E, et al. Lipids in the nervous system: from biochemistry and molecular biology to patho-physiology. Biochim Biophys Acta. 2015;1851:51\u201360.","journal-title":"Biochim Biophys Acta"},{"key":"2512_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcdb.2020.07.017","volume":"112","author":"JA Lee","year":"2021","unstructured":"Lee JA, Hall B, Allsop J, Alqarni R, Allen SP. Lipid metabolism in astrocytic structure and function. Semin Cell Dev Biol. 2021;112:123\u201336.","journal-title":"Semin Cell Dev Biol"},{"key":"2512_CR26","doi-asserted-by":"publisher","first-page":"eadc9317","DOI":"10.1126\/sciadv.adc9317","volume":"8","author":"JH Yoon","year":"2022","unstructured":"Yoon JH, Seo Y, Jo YS, Lee S, Cho E, Cazenave-Gassiot A, et al. Brain lipidomics: From functional landscape to clinical significance. Sci Adv. 2022;8:eadc9317.","journal-title":"Sci Adv."},{"key":"2512_CR27","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1038\/s41380-020-0645-4","volume":"26","author":"J Pu","year":"2021","unstructured":"Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2021;26:4265\u201376.","journal-title":"Mol Psychiatry"},{"issue":"31","key":"2512_CR28","first-page":"448","volume":"2021","author":"C Shimamoto-Mitsuyama","year":"1991","unstructured":"Shimamoto-Mitsuyama C, Nakaya A, Esaki K, Balan S, Iwayama Y, Ohnishi T, et al. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cereb Cortex N Y N. 1991;2021(31):448\u201362.","journal-title":"Cereb Cortex N Y N"},{"key":"2512_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10545-018-0158-3","volume":"41","author":"RJT Mocking","year":"2018","unstructured":"Mocking RJT, Assies J, Ruh\u00e9 HG, Schene AH. Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders. J Inherit Metab Dis. 2018;41:597\u2013611.","journal-title":"J Inherit Metab Dis"},{"key":"2512_CR30","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.neubiorev.2022.104970","volume":"144","author":"N van de Burgt","year":"2023","unstructured":"van de Burgt N, van Doesum W, Grevink M, van Niele S, de Koning T, Leibold N, et al. Psychiatric manifestations of inborn errors of metabolism: A systematic review. Neurosci Biobehav Rev. 2023;144: 104970.","journal-title":"Neurosci Biobehav Rev"},{"key":"2512_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.addr.2020.04.009","volume":"159","author":"D van Kruining","year":"2020","unstructured":"van Kruining D, Luo Q, van Echten-Deckert G, Mielke MM, Bowman A, Ellis S, et al. Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods. Adv Drug Deliv Rev. 2020;159:232\u201344.","journal-title":"Adv Drug Deliv Rev"},{"key":"2512_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fpsyt.2018.00459","volume":"9","author":"A Walther","year":"2018","unstructured":"Walther A, Cannistraci CV, Simons K, Dur\u00e1n C, Gerl MJ, Wehrli S, et al. Lipidomics in Major Depressive Disorder. Front Psychiatry. 2018;9:459.","journal-title":"Front Psychiatry"},{"key":"2512_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/0253717620944612","volume":"42","author":"P Vats","year":"2020","unstructured":"Vats P, Das B, Khanra S. Responses to the Comments on \u201cSerum Lipids Among Drug Na\u00efve or Drug-Free Patients with Obsessive Compulsive Disorder and Their Association with Impulsivity: A Comparative Study.\u201d Indian J Psychol Med. 2020;42:486.","journal-title":"Indian J Psychol Med"},{"issue":"36","key":"2512_CR34","first-page":"125","volume":"2014","author":"D De Berardis","year":"1999","unstructured":"De Berardis D, Serroni N, Marini S, Rapini G, Carano A, Valchera A, et al. Alexithymia, suicidal ideation, and serum lipid levels among drug-na\u00efve outpatients with obsessive-compulsive disorder. Rev Bras Psiquiatr Sao Paulo Braz. 1999;2014(36):125\u201330.","journal-title":"Rev Bras Psiquiatr Sao Paulo Braz"},{"key":"2512_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/070674370404901109","volume":"49","author":"MY Agargun","year":"2004","unstructured":"Agargun MY, Dulger H, Inci R, Kara H, Ozer OA, Sekeroglu MR, et al. Serum lipid concentrations in obsessive-compulsive disorder patients with and without panic attacks. Can J Psychiatry Rev Can Psychiatr. 2004;49:776\u20138.","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"2512_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pnpbp.2009.01.001","volume":"33","author":"S Chakraborty","year":"2009","unstructured":"Chakraborty S, Singh OP, Dasgupta A, Mandal N, Nath DH. Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:363\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2512_CR37","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1582-4934.2012.01543.x","volume":"16","author":"AG Woods","year":"2012","unstructured":"Woods AG, Sokolowska I, Taurines R, Gerlach M, Dudley E, Thome J, et al. Potential biomarkers in psychiatry: focus on the cholesterol system. J Cell Mol Med. 2012;16:1184\u201395.","journal-title":"J Cell Mol Med"},{"key":"2512_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiat. 2015;72:334\u201341.","journal-title":"JAMA Psychiat"},{"key":"2512_CR39","unstructured":"World Health Organization. ICD-10\u202f: international statistical classification of diseases and related health problems\u202f: tenth revision, 2nd ed. 10th ed. 2004. Available from: https:\/\/iris.who.int\/handle\/10665\/42980."},{"key":"2512_CR40","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 4th ed. Washington: American Psychiatric Association; 1994.","edition":"4"},{"key":"2512_CR41","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) [Internet]. 4th ed. Arlington, VA: American Psychiatric Association; 2000 [cited 2024 Dec 26]. Available from: http:\/\/www.psychiatryonline.com\/resourceTOC.aspx?resourceID=1."},{"key":"2512_CR42","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association; 2013 [cited 2024 Dec 26]. Available from: https:\/\/psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2512_CR43","unstructured":"Ryan R, Hill S. How to GRADE the quality of the evidence. Version 3.0. Cochrane Consumers and Communication Group; 2016. Available from: http:\/\/cccrg.cochrane.org\/author-resources."},{"key":"2512_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178\u201389.","journal-title":"J Clin Epidemiol"},{"key":"2512_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/jamapsychiatry.2022.4350","volume":"80","author":"A Tkachev","year":"2023","unstructured":"Tkachev A, Stekolshchikova E, Vanyushkina A, Zhang H, Morozova A, Zozulya S, et al. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder. JAMA Psychiat. 2023;80:250\u20139.","journal-title":"JAMA Psychiat"},{"key":"2512_CR46","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/s41598-023-29117-7","volume":"13","author":"AT Kopylov","year":"2023","unstructured":"Kopylov AT, Stepanov AA, Butkova TV, Malsagova KA, Zakharova NV, Kostyuk GP, et al. Consolidation of metabolomic, proteomic, and GWAS data in connective model of schizophrenia. Sci Rep. 2023;13:2139.","journal-title":"Sci Rep"},{"key":"2512_CR47","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/tp.2012.76","volume":"2","author":"Y He","year":"2012","unstructured":"He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, et al. Schizophrenia shows a unique metabolomics signature in plasma. Transl Psychiatry. 2012;2: e149.","journal-title":"Transl Psychiatry"},{"key":"2512_CR48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neurobiolaging.2009.02.017","volume":"32","author":"J-M Kim","year":"2011","unstructured":"Kim J-M, Stewart R, Kim S-W, Shin I-S, Yang S-J, Yoon J-S. Cholesterol and serotonin transporter polymorphism interactions in late-life depression. Neurobiol Aging. 2011;32:336\u201343.","journal-title":"Neurobiol Aging"},{"key":"2512_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41398-020-0804-z","volume":"10","author":"M Alemany-Navarro","year":"2020","unstructured":"Alemany-Navarro M, Cruz R, Real E, Segal\u00e0s C, Bertol\u00edn S, Rabionet R, et al. Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study. Transl Psychiatry. 2020;10:151.","journal-title":"Transl Psychiatry"},{"key":"2512_CR50","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1007\/s11033-019-04860-1","volume":"46","author":"S Alinaghi","year":"2019","unstructured":"Alinaghi S, Alehabib E, Johari AH, Vafaei F, Salehi S, Darvish H, et al. Expression analysis and genotyping of DGKZ: a GWAS-derived risk gene for schizophrenia. Mol Biol Rep. 2019;46:4105\u201311.","journal-title":"Mol Biol Rep"},{"key":"2512_CR51","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ajhg.2009.11.003","volume":"85","author":"HM Knight","year":"2009","unstructured":"Knight HM, Pickard BS, Maclean A, Malloy MP, Soares DC, McRae AF, et al. A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. Am J Hum Genet. 2009;85:833\u201346.","journal-title":"Am J Hum Genet"},{"key":"2512_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/YPG.0b013e32834acc85","volume":"21","author":"C Xie","year":"2011","unstructured":"Xie C, Wang ZC, Liu XF, Wang L, Yang MS. Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population. Psychiatr Genet. 2011;21:307\u201314.","journal-title":"Psychiatr Genet"},{"key":"2512_CR53","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1016\/j.celrep.2018.08.022","volume":"24","author":"I Kushima","year":"2018","unstructured":"Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, et al. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Cell Rep. 2018;24:2838\u201356.","journal-title":"Cell Rep"},{"key":"2512_CR54","doi-asserted-by":"publisher","first-page":"17410","DOI":"10.18632\/oncotarget.8202","volume":"7","author":"H-F Ji","year":"2016","unstructured":"Ji H-F, Zhuang Q-S, Shen L. Genetic overlap between type 2 diabetes and major depressive disorder identified by bioinformatics analysis. Oncotarget. 2016;7:17410\u20134.","journal-title":"Oncotarget"},{"key":"2512_CR55","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1017\/S0033291720000951","volume":"51","author":"H-C So","year":"2021","unstructured":"So H-C, Chau CK-L, Cheng Y-Y, Sham PC. Causal relationships between blood lipids and depression phenotypes: a Mendelian randomisation analysis. Psychol Med. 2021;51:2357\u201369.","journal-title":"Psychol Med."},{"key":"2512_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41398-020-01084-x","volume":"10","author":"DA Maas","year":"2020","unstructured":"Maas DA, Martens MB, Priovoulos N, Zuure WA, Homberg JR, Nait-Oumesmar B, et al. Key role for lipids in cognitive symptoms of schizophrenia. Transl Psychiatry. 2020;10:399.","journal-title":"Transl Psychiatry"},{"key":"2512_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41398-021-01527-z","volume":"11","author":"L R\u00f8devand","year":"2021","unstructured":"R\u00f8devand L, Bahrami S, Frei O, Chu Y, Shadrin A, O\u2019Connell KS, et al. Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes. Transl Psychiatry. 2021;11:407.","journal-title":"Transl Psychiatry"},{"key":"2512_CR58","doi-asserted-by":"publisher","first-page":"e1010161","DOI":"10.1371\/journal.pgen.1010161","volume":"18","author":"K Torgersen","year":"2022","unstructured":"Torgersen K, Rahman Z, Bahrami S, Hindley GFL, Parker N, Frei O, et al. Shared genetic loci between depression and cardiometabolic traits. PLoS Genet. 2022;18: e1010161.","journal-title":"PLoS Genet"},{"key":"2512_CR59","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1176\/appi.ajp.20220660","volume":"180","author":"L R\u00f8devand","year":"2023","unstructured":"R\u00f8devand L, Rahman Z, Hindley GFL, Smeland OB, Frei O, Tekin TF, et al. Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors. Am J Psychiatry. 2023;180:815\u201326.","journal-title":"Am J Psychiatry"},{"key":"2512_CR60","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","volume":"8","author":"HJ Jones","year":"2021","unstructured":"Jones HJ, Borges MC, Carnegie R, Mongan D, Rogers PJ, Lewis SJ, et al. Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study. Lancet Psychiatry. 2021;8:1062\u201370.","journal-title":"Lancet Psychiatry"},{"key":"2512_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/pcn.13372","volume":"76","author":"R Aoki","year":"2022","unstructured":"Aoki R, Saito T, Ninomiya K, Shimasaki A, Ashizawa T, Ito K, et al. Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets. Psychiatry Clin Neurosci. 2022;76:361\u20136.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2512_CR62","doi-asserted-by":"publisher","first-page":"sgac001","DOI":"10.1093\/schizbullopen\/sgac001","volume":"3","author":"BI Perry","year":"2022","unstructured":"Perry BI, Bowker N, Burgess S, Wareham NJ, Upthegrove R, Jones PB, et al. Evidence for Shared Genetic Aetiology Between Schizophrenia, Cardiometabolic, and Inflammation-Related Traits: Genetic Correlation and Colocalization Analyses. Schizophr Bull Open. 2022;3:sgac001.","journal-title":"Schizophr Bull Open."},{"key":"2512_CR63","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/jamapsychiatry.2023.0685","volume":"80","author":"N Amin","year":"2023","unstructured":"Amin N, Liu J, Bonnechere B, MahmoudianDehkordi S, Arnold M, Batra R, et al. Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals. JAMA Psychiat. 2023;80:597\u2013609.","journal-title":"JAMA Psychiat"},{"key":"2512_CR64","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41380-023-02180-2","volume":"28","author":"A van der Spek","year":"2023","unstructured":"van der Spek A, Stewart ID, K\u00fchnel B, Pietzner M, Alshehri T, Gau\u00df F, et al. Circulating metabolites modulated by diet are associated with depression. Mol Psychiatry. 2023;28:3874\u201387.","journal-title":"Mol Psychiatry"},{"key":"2512_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12920-023-01692-8","volume":"16","author":"B Li","year":"2023","unstructured":"Li B, Qu Y, Fan Z, Gong X, Xu H, Wu L, et al. Causal relationships between blood lipids and major psychiatric disorders: Univariable and multivariable mendelian randomization analysis. BMC Med Genomics. 2023;16:250.","journal-title":"BMC Med Genomics"},{"key":"2512_CR66","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jad.2023.04.114","volume":"335","author":"W Huang","year":"2023","unstructured":"Huang W, Wang Z, Zou C, Liu Y, Pan Y, Lu J, et al. Effects of metabolic factors in mediating the relationship between Type 2 diabetes and depression in East Asian populations: A two-step, two-sample Mendelian randomization study. J Affect Disord. 2023;335:120\u20138.","journal-title":"J Affect Disord"},{"key":"2512_CR67","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41398-024-02932-w","volume":"14","author":"R Carnegie","year":"2024","unstructured":"Carnegie R, Borges MC, Jones HJ, Zheng J, Haycock P, Evans J, et al. Omega-3 fatty acids and major depression: a Mendelian randomization study. Transl Psychiatry. 2024;14:222.","journal-title":"Transl Psychiatry"},{"key":"2512_CR68","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.biopsych.2024.02.1005","volume":"96","author":"D Stacey","year":"2024","unstructured":"Stacey D, Benyamin B, Lee SH, Hypp\u00f6nen E. A Metabolome-Wide Mendelian Randomization Study Identifies Dysregulated Arachidonic Acid Synthesis as a Potential Causal Risk Factor for Bipolar Disorder. Biol Psychiatry. 2024;96:455\u201362.","journal-title":"Biol Psychiatry"},{"key":"2512_CR69","doi-asserted-by":"publisher","first-page":"e301230","DOI":"10.1136\/bmjment-2024-301230","volume":"27","author":"D Freuer","year":"2024","unstructured":"Freuer D, Meisinger C. Mediation-adjusted multivariable Mendelian randomisation study identified novel metabolites related to mental health. BMJ Ment Health. 2024;27: e301230.","journal-title":"BMJ Ment Health"},{"key":"2512_CR70","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/schbul\/sbac130","volume":"49","author":"Y Jia","year":"2023","unstructured":"Jia Y, Hui L, Sun L, Guo D, Shi M, Zhang K, et al. Association Between Human Blood Metabolome and the Risk of Psychiatric Disorders. Schizophr Bull. 2023;49:428\u201343.","journal-title":"Schizophr Bull"},{"key":"2512_CR71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jad.2024.03.098","volume":"355","author":"F Chen","year":"2024","unstructured":"Chen F, Dong X, Yu Z, Zhang Y, Shi Y. The brain-heart axis: Integrative analysis of the shared genetic etiology between neuropsychiatric disorders and cardiovascular disease. J Affect Disord. 2024;355:147\u201356.","journal-title":"J Affect Disord"},{"key":"2512_CR72","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","volume":"16","author":"ZN Sohani","year":"2015","unstructured":"Sohani ZN, Meyre D, de Souza RJ, Joseph PG, Gandhi M, Dennis BB, et al. Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genet. 2015;16:50.","journal-title":"BMC Genet"},{"key":"2512_CR73","doi-asserted-by":"publisher","first-page":"107710","DOI":"10.1016\/j.jdiacomp.2020.107710","volume":"34","author":"K Inoue","year":"2020","unstructured":"Inoue K, Beekley J, Goto A, Jeon CY, Ritz BR. Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis. J Diabetes Complications. 2020;34: 107710.","journal-title":"J Diabetes Complications"},{"key":"2512_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcjd.2014.11.006","volume":"39","author":"M Yu","year":"2015","unstructured":"Yu M, Zhang X, Lu F, Fang L. Depression and Risk for Diabetes: A Meta-Analysis. Can J Diabetes. 2015;39:266\u201372.","journal-title":"Can J Diabetes"},{"key":"2512_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2018.08.012","volume":"193","author":"M Lacy","year":"2019","unstructured":"Lacy M, Atzler D, Liu R, de Winther M, Weber C, Lutgens E. Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis. Pharmacol Ther. 2019;193:50\u201362.","journal-title":"Pharmacol Ther"},{"key":"2512_CR76","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107:234\u201356.","journal-title":"Neuron"},{"key":"2512_CR77","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2020.06.028","volume":"159","author":"A Leuti","year":"2020","unstructured":"Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev. 2020;159:133\u201369.","journal-title":"Adv Drug Deliv Rev"},{"issue":"Suppl 1","key":"2512_CR78","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.freeradbiomed.2014.10.753","volume":"75","author":"A De Bem","year":"2014","unstructured":"De Bem A, Engel D, de Oliveira J, Moreira ELG, Neis VB, Santos DB, et al. Hypercholesterolemia as a risk factor for depressive disorder? Free Radic Biol Med. 2014;75(Suppl 1):S28.","journal-title":"Free Radic Biol Med"},{"key":"2512_CR79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbr.2016.05.029","volume":"311","author":"DF Engel","year":"2016","unstructured":"Engel DF, de Oliveira J, Lopes JB, Santos DB, Moreira ELG, Farina M, et al. Is there an association between hypercholesterolemia and depression? Behavioral evidence from the LDLr(-\/-) mouse experimental model. Behav Brain Res. 2016;311:31\u20138.","journal-title":"Behav Brain Res"},{"key":"2512_CR80","doi-asserted-by":"publisher","first-page":"e1003455","DOI":"10.1371\/journal.pmed.1003455","volume":"18","author":"BI Perry","year":"2021","unstructured":"Perry BI, Burgess S, Jones HJ, Zammit S, Upthegrove R, Mason AM, et al. The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study. PLoS Med. 2021;18: e1003455.","journal-title":"PLoS Med"},{"key":"2512_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12263-024-00747-4","volume":"19","author":"I Loukil","year":"2024","unstructured":"Loukil I, Mutch DM, Plourde M. Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA\/DHA in humans: a scoping review. Genes Nutr. 2024;19:11.","journal-title":"Genes Nutr"},{"key":"2512_CR82","doi-asserted-by":"publisher","first-page":"100166","DOI":"10.1074\/jbc.RA120.015997","volume":"296","author":"M Nakato","year":"2021","unstructured":"Nakato M, Shiranaga N, Tomioka M, Watanabe H, Kurisu J, Kengaku M, et al. ABCA13 dysfunction associated with psychiatric disorders causes impaired cholesterol trafficking. J Biol Chem. 2021;296: 100166.","journal-title":"J Biol Chem"},{"key":"2512_CR83","first-page":"257","volume":"149","author":"G Chaldakov","year":"2011","unstructured":"Chaldakov G. The metabotrophic NGF and BDNF: an emerging concept. Arch Ital Biol. 2011;149:257\u201363.","journal-title":"Arch Ital Biol"},{"key":"2512_CR84","doi-asserted-by":"publisher","first-page":"e0116701","DOI":"10.1371\/journal.pone.0116701","volume":"10","author":"T Pohlkamp","year":"2015","unstructured":"Pohlkamp T, Durakoglugil M, Lane-Donovan C, Xian X, Johnson EB, Hammer RE, et al. Lrp4 domains differentially regulate limb\/brain development and synaptic plasticity. PLoS ONE. 2015;10: e0116701.","journal-title":"PLoS ONE"},{"key":"2512_CR85","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/aur.2659","volume":"15","author":"A Jutla","year":"2022","unstructured":"Jutla A, Foss-Feig J, Veenstra-VanderWeele J. Autism spectrum disorder and schizophrenia: An updated conceptual review. Autism Res Off J Int Soc Autism Res. 2022;15:384\u2013412.","journal-title":"Autism Res Off J Int Soc Autism Res"},{"key":"2512_CR86","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.metabol.2009.10.022","volume":"59","author":"C Glaser","year":"2010","unstructured":"Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism. 2010;59:993\u20139.","journal-title":"Metabolism"},{"key":"2512_CR87","doi-asserted-by":"publisher","first-page":"1150458","DOI":"10.3389\/fgene.2023.1150458","volume":"14","author":"N Saadullah Khani","year":"2023","unstructured":"Saadullah Khani N, Cotic M, Wang B, Abidoph R, Mills G, Richards-Belle A, et al. Schizophrenia and cardiometabolic abnormalities: A Mendelian randomization study. Front Genet. 2023;14:1150458.","journal-title":"Front Genet"},{"key":"2512_CR88","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/schbul\/sbab132","volume":"48","author":"RR Veeneman","year":"2022","unstructured":"Veeneman RR, Vermeulen JM, Abdellaoui A, Sanderson E, Wootton RE, Tadros R, et al. Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study. Schizophr Bull. 2022;48:463\u201373.","journal-title":"Schizophr Bull"},{"key":"2512_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40413-017-0151-6","volume":"10","author":"SN Gonz\u00e1lez-D\u00edaz","year":"2017","unstructured":"Gonz\u00e1lez-D\u00edaz SN, Arias-Cruz A, Elizondo-Villarreal B, Monge-Ortega OP. Psychoneuroimmunoendocrinology: clinical implications. World Allergy Organ J. 2017;10:19.","journal-title":"World Allergy Organ J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02512-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02512-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:43:26Z","timestamp":1741848206000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02512-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02512-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}